Drug intelligence / Profile preview

shDDR1

Development stage
Preclinical
Lead developer
University of Michigan
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

shDDR1 is a short hairpin RNA (shRNA) construct designed to silence the expression of discoidin domain receptor 1 (DDR1), a collagen-binding receptor tyrosine kinase. In the context of glioblastoma (GBM), DDR1 is often overexpressed and plays a critical role in maintaining an immunosuppressive tumor microenvironment by promoting the alignment of collagen fibers and the formation of 'oncostreams'—multicellular structures that facilitate tumor cell invasion. By knocking down DDR1 expression, shDDR1 aims to remodel the extracellular matrix, enhance the infiltration of CD45+ and CD3+ immune cells into the tumor core, and increase the sensitivity of glioma cells to radiotherapy. Preclinical studies using the Sleeping Beauty transposase system in genetically engineered mouse models have demonstrated that DDR1 knockdown significantly prolongs median survival and reduces the presence of glioma-associated microglia.

Other names
DDR1 shRNADDR-1 shRNADDR 1 shRNAshort hairpin RNA targeting DDR1
02

Targets

DDR1 (Discoidin domain receptor 1)Discoidin domain-containing receptor 1 mRNA

Beyond the preview

Go deeper on shDDR1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shDDR1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call